Gene-expression profiling of the early stages of MOG-induced EAE proves EAE-resistance as an active process

Journal of Neuroimmunology

Volumn 151, Issue 1-2, 2004, Pages 158-170

  Mix, Eilhard ^a   Ibrahim, Saleh ^a   Pahnke, Jens ^a,b   Koczan, Dirk ^a   Sina, Christian ^a   Böttcher, Tobias ^a   Thiesen, Hans Jürgen ^a   Rolfs, Arndt ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

EAE; EST; experimental autoimmune encephalomyelitis; Experimental autoimmune encephalomyelitis (EAE); expressed sequence tag; Lymph node cells; Multiple sclerosis (MS); Oligonucleotide microarrays; Quantitative trait locus (QTL); Susceptibility genes

Indexed keywords

MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROL GROUP; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION; HYPOTHESIS; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOREACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; LYMPH NODE; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; INTERFERON TYPE II; LYMPH NODES; MICE; MONOCYTES; MULTIPLE SCLEROSIS; MYELIN-ASSOCIATED GLYCOPROTEIN; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION;

EID: 2442474161     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2004.03.007     Document Type: Article

References (49)

1. Agrawal D., Chen T., Irby R., Quackenbush J., Chambers A.F., Szabo M., Cantor A., Coppola D., Yeatman T.J. Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J. Natl. Cancer Inst. 94:2002;513-521
2. Barnes J.W., Tischkau S.A., Barnes J.A., Mitchell J.W., Burgoon P.W., Hickok J.R., Gillette M.U. Requirement of mammalian timeless for circadian rhythmicity. Science. 302:2003;439-442
3. Becanovic K., Wallstrom E., Kornek B., Glaser A., Broman K.W., Dahlman I., Olofsson P., Holmdahl R., Luthman H., Lassmann H., Olsson T. New loci regulating rat myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. J. Immunol. 170:2003;1062-1069
4. Bomprezzi R., Ringner M., Kim S., Bittner M.L., Khan J., Chen Y., Elkahloun A., Yu A., Bielekova B., Meltzer P.S., Martin R., McFarland H.F., Trent J.M. Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease. Hum. Mol. Genet. 12:2003;2191-2199
5. Böttcher T., Mix E., Koczan D., Bauer P., Pahnke J., Peters S., Weinelt S., Knoblich R., Strauss U., Cattaneo E., Thiesen H.-J., Rolfs A. Gene expression profiling of CNTF-overexpressing rat striatal progenitor cells (ST14A) indicates improved stress-response during early stage of differentiation. J. Neurosci. Res. 73:2003;42-53
6. Carmody R.J., Hilliard B., Maguschak K., Chodosh L.A., Chen Y.H. Genomic scale profiling of autoimmune inflammation in the central nervous system: the nervous response to inflammation. J. Neuroimmunol. 133:2002;95-107
7. Chabas D., Baranzini S.E., Mitchell D., Bernard C.C., Rittling S.R., Denhardt D.T., Sobel R.A., Lock C., Karpuj M., Pedotti R., Heller R., Oksenberg J.R., Steinman L. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science. 294:2001;1731-1735
8. Costa O., Divoux D., Ischenko A., Tron F., Fontaine M. Optimization of an animal model of experimental autoimmune encephalomyelitis achieved with a multiple MOG(35-55)peptide in C57BL6/J strain of mice. J. Autoimmun. 20:2003;51-61
9. Dahlman I., Wallstrom E., Weissert R., Storch M., Kornek B., Jacobsson L., Linington C., Luthman H., Lassmann H., Olsson T. Linkage analysis of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in the rat identifies a locus controlling demyelination on chromosome 18. Hum. Mol. Genet. 8:1999;2183-2190
10. Encinas J.A., Lees M.B., Sobel R.A., Symonowicz C., Greer J.M., Shovlin C.L., Weiner H.L., Seidman C.E., Seidman J.G., Kuchroo V.K. Genetic analysis of susceptibility to experimental autoimmune encephalomyelitis in a cross between SJL/J and B10 S mice. J. Immunol. 157:1996;2186-2192
11. Ibrahim S.M., Mix E., Böttcher T., Koczan D., Gold R., Rolfs A., Thiesen H.J. Gene expression profiling of the nervous system in murine experimental autoimmune encephalomyelitis. Brain. 124:2001;1927-1938
12. Jagodic M., Kornek B., Weissert R., Lassmann H., Olsson T., Dahlman I. Congenic mapping confirms a locus on rat chromosome 10 conferring strong protection against myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. Immunogenetics. 53:2001;410-415
13. Jaster R., Bittorf T., Klinken S.P., Brock J. Inhibition of proliferation but not erythroid differentiation of J2E cells by rapamycin. Biochem. Pharmacol. 51:1996;1181-1185
14. Kendziorski C.M., Zhang Y., Lan H., Attie A.D. The efficiency of mRNA pooling in microarray experiments. Biostatistics. 4:2003;465-477
15. King M.C., Marks J.H., Mandell J.B. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science. 302:2003;643-646
16. Koike F., Satoh J., Miyake S., Yamamoto T., Kawai M., Kikuchi S., Nomura K., Yokomyama K., Ota K., Kanda T., Fukazawa T., Yamamura T. Microarray analysis identifies interferon beta-regulated gene in multiple sclerosis. J. Neuroimmunol. 139:2003;109-118
17. Lock C., Hermans G., Pedotti R., Brendolan A., Schadt E., Garren H., Langer-Gould A., Strober S., Cannella B., Allard J., Klonowski P., Austin A., Lad N., Kaminski N., Galli S.J., Oksenberg J.R., Raine C.S., Heller R., Steinman L. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8:2002;500-508
18. Lucchinetti C., Bruck W., Parisi J., Scheithauer B., Rodriguez M., Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 47:2000;707-717
19. Masat L., Caldwell J., Armstrong R., Khoshnevisan H., Jessberger R., Herndier B., Wabl M., Ferrick D. Association of Swap-70 with the B cell antigen receptor complex. Proc. Natl. Acad. Sci. U. S. A. 97:2000;2180-2184
20. Matejuk A., Dwyer J., Zamora A., Vandenbark A.A., Offner H. Evaluation of the effects of 17beta-estradiol (17beta-e2) on gene expression in experimental autoimmune encephalomyelitis using DNA microarray. Endocrinology. 143:2002;313-319
21. Matejuk A., Hopke C., Dwyer J., Subramanian S., Jones R.E., Bourdette D.N., Vandenbark A.A., Offner H. CNS gene expression pattern associated with spontaneous experimental autoimmune encephalomyelitis. J. Neurosci. Res. 73:2003;667-678
22. Miller R.A., Galecki A., Shmookler-Reis R.J. Interpretation, design, and analysis of gene array expression experiments. J. Gerontol., Ser. A, Biol. Sci. Med. Sci. 56:2001;B52-B57
23. Mix E., Pahnke J., Ibrahim S.M. Gene-expression profiling of experimental autoimmune encephalomyelitis. Neurochem. Res. 27:2002;1157-1163
24. Mycko M.P., Papoian R., Boschert U., Raine C.S., Selmaj K.W. cDNA microarray analysis in multiple sclerosis lesions: detection of genes associated with disease activity. Brain. 126:2003;1048-1057
25. Neumann H., Medana I.M., Bauer J., Lassmann H. Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci. 25:2002;313-319
26. Nicot A., Ratnakar P.V., Ron Y., Chen C.C., Elkabes S. Regulation of gene expression in experimental autoimmune encephalomyelitis indicates early neuronal dysfunction. Brain. 126:2003;398-412
27. Pahnke J., Mix E., Schubert B., Knoblich R., Müller J., Zschiesche M., Koczan D., Bauer P., Böttcher T., Thiesen H.-J., Lazarou L., Wree A., Rolfs A. Overexpression of glial cell line-derived neurotrophic factor induces genes regulating migration and differentiation of neuronal progenitor cells. Exp. Cell Res. 2004; (in press) doi:10.1016/j.yexcr.2004.03.037
28. Pedotti R., DeVoss J.J., Youssef S., Mitchell D., Wedemeyer J., Madanat R., Garren H., Fontoura P., Tsai M., Galli S.J., Sobel R.A., Steinman L. Multiple elements of the allergic arm of the immune response modulate autoimmune demyelination. Proc. Natl. Acad. Sci. U. S. A. 100:2003;1867-1872
29. Peng, X., Wood, C.L., Blalock, E.M., Chen, K.C., Landfield, P.W., Stromberg, A.J., 2003. Statistical implications of pooling RNA samples for microarray experiments. BMC Bioinformatics. 4, 26-34 (available from: http://biomedcentral.com/1471-2105/4/26).
30. Pletcher S.D., Macdonald S.J., Marguerie R., Certa U., Stearns S.C., Goldstein D.B., Partridge L. Genome-wide transcript profiles in aging and calorically restricted Drosophila melanogaster. Curr. Biol. 12:2002;712-723
31. Ramanathan M., Weinstock-Guttman B., Nguyen L.T., Badgett D., Miller C., Patrick K., Brownscheidle C., Jacobs L. In vivo gene expression revealed by cDNA arrays: the pattern in relapsing remitting multiple sclerosis patients compared with normal subjects. J. Neuroimmunol. 116:2001;213-219
32. Saeguse K., Ishimaru N., Yanagi K., Arakaki R., Ogawa K., Saito I., Katunuma N., Hayashi Y. Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity. J. Clin. Invest. 110:2002;361-369
33. Silva J.M., Dominguez G., Gonzalez-Sancho J.M., Garcia J.M., Silva J., Garcia-Andrade C., Navarro A., Munoz A., Bonilla F. Expression of thyroid hormone receptor/erbA genes is altered in human breast cancer. Oncogene. 21:2002;4307-4316
34. Skundric D.S., Zakarian V., Dai R., Lisak R.P., Tse H.Y., James J. Distinct immune regulation of the response to H-2b restricted epitope of MOG causes relapsing-remitting EAE in H-2b/s mice. J. Neuroimmunol. 136:2003;34-45
35. Snaddon J., Smith M.L., Neat M., Cambal-Parrales M., Dixon-McIver A., Arch R., Amess J.A., Rohatiner A.Z., Lister T.A., Fitzgibbon J. Mutations of CEBPA in acute myeloid leukemia FAB types M1 and M2. Genes Chromosomes Cancer. 37:2003;72-78
36. Steinman L. Assessment of the utility of animal models for MS and demyelinating diseases in the design of rational therapy. Neuron. 24:1999;511-514
37. Steinman L., Zamvil S. Transcriptional analysis of targets in multiple sclerosis. Nat. Rev., Immunol. 3:2003;483-492
38. Storch M.K., Stefferl A., Brehm U., Weissert R., Wallstrom E., Kerschensteiner M., Olsson T., Linington C., Lassmann H. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol. 8:1998;681-694
39. Stürzebecher S., Wandinger K.P., Rosenwald A., Sathyamoorthy M., Tzou A., Mattar P., Frank J.A., Staudt L., Martin R., McFarland H.F. Expression profiling identifies responder and non-responder phenotypes to interferon-β in multiple sclerosis. Brain. 126:2003;1419-1429
40. Takeuchi A., Mishina Y., Miyaishi O., Kojima E., Hasegawa T., Isobe K. Heterozygosity with respect to Zfp148 causes complete loss of fetal germ cells during mouse embryogenesis. Nat. Genet. 33:2003;172-176
41. Trapp B.D., Peterson J., Ransohoff R.M., Rudick R., Mork S., Bo L. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338:1998;278-285
42. Waldner H., Sobel R.A., Howard E., Kuchroo V.K. Fas- and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis. J. Immunol. 159:1997;3100-3103
43. Wandinger K.P., Sturzebecher C.S., Bielekova B., Detore G., Rosenwald A., Staudt L.M., McFarland H.F., Martin R. Complex immunomodulatory effects of interferon-beta in multiple sclerosis include the up-regulation of T helper 1-associated marker genes. Ann. Neurol. 50:2001;349-357
44. Weissert R., de Graaf K.L., Storch M.K., Barth S., Linington C., Lassmann H., Olsson T. MHC class II-regulated central nervous system autoaggression and T cell responses in peripheral lymphoid tissues are dissociated in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. J. Immunol. 166:2001;7588-7599
45. Whitney L.W., Becker K.G., Tresser N.J., Caballero-Ramos C.I., Munson P.J., Prabhu V.V., Trent J.M., McFarland H.F., Biddison W.E. Analysis of gene expression in multiple sclerosis lesions using cDNA microarrays. Ann. Neurol. 46:1999;425-428
46. Whitney L.W., Ludwin S.K., McFarland H.F., Biddison W.E. Microarray analysis of gene expression in multiple sclerosis and EAE identifies 5-lipoxygenase as a component of inflammatory lesions. J. Neuroimmunol. 121:2001;40-48
47. Yoh S.M., Privalsky M.L. Transcriptional repression by thyroid hormone receptors. A role for receptor homodimers in the recruitment of SMRT corepressor. J. Biol. Chem. 276:2001;16857-16867
48. Youssef S., Stuve O., Patarroyo J.C., Ruiz P.J., Radosevich J.L., Hur E.M., Bravo M., Mitchell D.J., Sobel R.A., Steinman L., Zamvil S.S. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature. 420:2002;78-84
49. Zamvil S.S., Steinman L. Diverse targets for intervention during inflammatory and neurodegenerative phases of multiple sclerosis. Neuron. 38:2003;685-688